These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7510614)

  • 21. Ranitidine and acute intermittent porphyria.
    Bhadoria DP; Srivastava AK; Sharma M; Deswal A; Malhotra KK
    J Assoc Physicians India; 1988 Apr; 36(4):295-6. PubMed ID: 3182690
    [No Abstract]   [Full Text] [Related]  

  • 22. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranitidine: a new H2-receptor antagonist.
    Zeldis JB; Friedman LS; Isselbacher KJ
    N Engl J Med; 1983 Dec; 309(22):1368-73. PubMed ID: 6314139
    [No Abstract]   [Full Text] [Related]  

  • 25. Ranitidine in short supply: why now, and where next?
    Ryan ME; Barker C; Hawcutt DB
    Arch Dis Child; 2020 Apr; 105(4):382-383. PubMed ID: 31848148
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical development programme for omeprazole.
    Walan A
    Digestion; 1990; 47 Suppl 1():54-8; discussion 76. PubMed ID: 2093016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy with H2 receptor antagonists in childhood. Use of ranitidine in duodenal and gastric ulcer and reflux esophagitis].
    Bender SW
    Fortschr Med; 1992 Nov; 110(33):629-32. PubMed ID: 1478605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranitidine in the management of gastric ulcer.
    Colin-Jones DG
    Indian J Gastroenterol; 1986 Oct; 5 Suppl():15-6. PubMed ID: 3793161
    [No Abstract]   [Full Text] [Related]  

  • 29. Rash mediated by immune complexes associated with ranitidine treatment.
    Haboubi N; Asquith P
    Br Med J (Clin Res Ed); 1988 Mar; 296(6626):897. PubMed ID: 2965952
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis associated with ranitidine.
    Souza Lima MA
    Ann Intern Med; 1984 Aug; 101(2):207-8. PubMed ID: 6331240
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Thomson AB; Mahachai V
    Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ranitidine and loss of colour vision in a child.
    De Giacomo C; Maggiore G; Scotta MS
    Lancet; 1984 Jul; 2(8393):47. PubMed ID: 6145972
    [No Abstract]   [Full Text] [Related]  

  • 33. [Long term management of peptic ulcer. Indications and side effects of drug therapy compared with surgical procedure].
    Rösch W
    Fortschr Med; 1984 Jul; 102(25-26):688-91. PubMed ID: 6088375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety experience from long-term treatment with omeprazole.
    Joelson S; Joelson IB; Lundborg P; Walan A; Wallander MA
    Digestion; 1992; 51 Suppl 1():93-101. PubMed ID: 1397750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible ranitidine hepatotoxicity.
    Black M; Scott WE; Kanter R
    Ann Intern Med; 1984 Aug; 101(2):208-10. PubMed ID: 6331241
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adverse effects of ulcer drugs before and after release of cimetidine, ranitidine and sucralfate for over-the-counter sale].
    Andersen M; Schou JS
    Ugeskr Laeger; 1991 May; 153(20):1410-3. PubMed ID: 1674181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of ranitidine on healing of peptic ulcer: a 2-month study.
    Leroux P; Farley A; Archambault A; Pilon G; Gosselin D; Paré P; Lévesque D; Sherbaniuk R; Thomson AB
    Am J Gastroenterol; 1983 Apr; 78(4):227-30. PubMed ID: 6301262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.
    Brunner G; Athmann C; Schneider A
    Aliment Pharmacol Ther; 2012 Jul; 36(1):37-47. PubMed ID: 22531114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of H2-receptor antagonists in children.
    Dimand RJ
    DICP; 1990 Nov; 24(11 Suppl):S42-6. PubMed ID: 2270695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic effects of the combination of traditional Chinese medicine and western medicine on patients with peptic ulcers].
    Zhou B; Li JB; Cai GX; Ling JH; Dai XP
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):714-8. PubMed ID: 16708818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.